Healthcare provider profile · identity verified

Michael Pothen, MD

Family Practice · MOUNT PLEASANT, WI · NPI 1124382999

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	695	165
Levothyroxine Sodium	Levothyroxine Sodium	490	86
Amlodipine Besylate	Amlodipine Besylate	419	100
Omeprazole	Omeprazole	378	75
Pantoprazole Sodium	Pantoprazole Sodium	377	80
Losartan Potassium	Losartan Potassium	324	78
Lisinopril	Lisinopril	317	83
Furosemide	Furosemide	287	63
Metformin Hcl	Metformin Hcl	279	73
Donepezil Hcl	Donepezil Hcl	277	45
Metoprolol Succinate	Metoprolol Succinate	272	56
Potassium Chloride	Potassium Chloride	260	55
Gabapentin	Gabapentin	204	39
Escitalopram Oxalate	Escitalopram Oxalate	203	34
Sertraline Hcl	Sertraline Hcl	194	38
Hydrochlorothiazide	Hydrochlorothiazide	164	41
Fluticasone Propionate	Fluticasone Propionate	154	48
Pravastatin Sodium	Pravastatin Sodium	150	38
Metoprolol Tartrate	Metoprolol Tartrate	147	29
Alprazolam	Alprazolam	144	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	141	31
Albuterol Sulfate Hfa	Albuterol Sulfate	139	48
Simvastatin	Simvastatin	136	33
Allopurinol	Allopurinol	135	33
Eliquis	Apixaban	132	25
Quetiapine Fumarate	Quetiapine Fumarate	115	18
Trazodone Hcl	Trazodone Hcl	113	22
Montelukast Sodium	Montelukast Sodium	108	26
Memantine Hcl	Memantine Hcl	104	15
Tamsulosin Hcl	Tamsulosin Hcl	104	21
Tramadol Hcl	Tramadol Hcl	99	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	92	28
Meloxicam	Meloxicam	88	17
Carvedilol	Carvedilol	86	17
Clopidogrel	Clopidogrel Bisulfate	86	23
Amoxicillin	Amoxicillin	83	69
Finasteride	Finasteride	75	14
Triamcinolone Acetonide	Triamcinolone Acetonide	74	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	12
Rosuvastatin Calcium	Rosuvastatin Calcium	69	17
Tizanidine Hcl	Tizanidine Hcl	63	17
Esomeprazole Magnesium	Esomeprazole Magnesium	62	suppressed
Nystatin	Nystatin	61	26
Bupropion Xl	Bupropion Hcl	60	13
Lovastatin	Lovastatin	60	12
Mirtazapine	Mirtazapine	60	suppressed
Enalapril Maleate	Enalapril Maleate	57	11
Duloxetine Hcl	Duloxetine Hcl	56	suppressed
Warfarin Sodium	Warfarin Sodium	56	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	56	13
Famotidine	Famotidine	55	16
Fenofibrate	Fenofibrate	55	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	18
Prednisone	Prednisone	53	37
Atenolol	Atenolol	52	12
Clonidine Hcl	Clonidine Hcl	51	20
Spironolactone	Spironolactone	50	12
Pregabalin	Pregabalin	49	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	13
Venlafaxine Hcl Er	Venlafaxine Hcl	49	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	33
Ropinirole Hcl	Ropinirole Hcl	48	11
Ketoconazole	Ketoconazole	47	16
Hydroxyzine Hcl	Hydroxyzine Hcl	46	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	11
Cefuroxime	Cefuroxime Axetil	45	40
Citalopram Hbr	Citalopram Hydrobromide	44	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	11
Lorazepam	Lorazepam	42	suppressed
Benazepril Hcl	Benazepril Hcl	41	suppressed
Xarelto	Rivaroxaban	41	suppressed
Meclizine Hcl	Meclizine Hcl	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	17
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Glipizide	Glipizide	37	12
Midodrine Hcl	Midodrine Hcl	35	suppressed
Naproxen	Naproxen	35	suppressed
Ipratropium Bromide	Ipratropium Bromide	34	14
Baclofen	Baclofen	31	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Ibuprofen	Ibuprofen	27	12
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Torsemide	Torsemide	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Lidocaine	Lidocaine	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Myrbetriq	Mirabegron	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Diazepam	Diazepam	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Azithromycin	Azithromycin	16	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	16
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	14	suppressed
Nystop	Nystatin	14	suppressed
Ondansetron Odt	Ondansetron	14	12
Valacyclovir	Valacyclovir Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Cyclobenzaprine Hcl Er	Cyclobenzaprine Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Methimazole	Methimazole	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Ozempic	Semaglutide	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Sodium Chloride	0.9 % Sodium Chloride	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Desloratadine	Desloratadine	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Nicardipine Hcl	Nicardipine Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Digoxin	Digoxin	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Naloxone Hcl	Naloxone Hcl	11	11
Novolog Flexpen	Insulin Aspart	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error